Evaluation of adsorption capacity of acetaminophen on activated charcoal dosage forms available in Nigeria by in vitro adsorption studies and scanning electron microscopy
Purpose: To investigate varying dosage forms of activated charcoal obtained from community pharmacy outlets in Nigeria for their adsorption capacity when challenged with acetaminophen.
Methods: Equilibruim kinetics of acetaminophen adsorption onto activated charcoal surface was determined via batch studies at different adsorbent: adsorbate ratios. The isotherm adsorption experiment was carried out at 37 oC and langmuir isotherm models were utilized to describe the equilibrium kinetics data with characterization of adsorption site and porosity elucidated via scanning electron microscopy.
Results: A preponderance of microporosity was observed on the surface of the powder activated charcoal. Maximum adsorption capacity (MAC) of 299.78 mg/g was obtained using activated charcoal powder (276.11; 321.09) at 95 % confidence interval (CI), allowing for maximum adsorption of acetaminophen at pH 1.2. Mixed pore structures, which were not clearly established, were observed with both the tablets and capsules with MAC of 280.54 mg/g (273.22; 290.08) and 140.01 mg/g (135.32; 153.99), respectively at pH 1.2. MAC data at pH 6.5 showed little variation from those obtained at pH 1.2 (p < 0.05 95 % CI).
Conclusion: The presence of excipients in the tablets and capsules caused a retardation in adsorption via intraparticle diffusion especially at basal micropore sites on the activated charcoal surface. Activated charcoal powder is superior to other dosage forms for use in countering acetaminophen poisoning.
Keywords: Acetaminophen, Adsorption, Isotherms, Activated charcoal, Scanning electron microcopy
Submission of a manuscript to this journal is a representation that the manuscript has not been published previously and is not under consideration for publication elsewhere.
All authors named in each manuscript would be required to sign a form (to be supplied by the Editor) so that they may retain their copyright in the article but to assign to us (the Publishers) and its licensees in perpetuity, in all forms, formats and media (whether known or created in the future) to (i) publish, reproduce, distribute, display and store the contribution, (ii) translate the contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or abstracts of the contribution, (iii) create any other derivative works(s) based on the contribution, (iv) to exploit all subsidiary rights in the contribution, (v) the inclusion of electronic links from the contribution to third party material where-ever it may be located, and (vi) license any thrid party to do any or all of the above.